The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

@article{Harsh2006TheEA,
  title={The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.},
  author={John R. Harsh and Roza Hayduk and Russell Rosenberg and Keith A Wesnes and James K Walsh and Sanjay Arora and Gwendolyn E Niebler and Thomas Roth},
  journal={Current medical research and opinion},
  year={2006},
  volume={22 4},
  pages={761-74}
}
OBJECTIVE This study assessed the efficacy and safety of armodafinil, the longer half-life enantiomer of modafinil, for the treatment of excessive sleepiness in patients with narcolepsy. RESEARCH DESIGN AND METHODS This was a multicenter double-blind study with 196 patients (aged 18-65 years) randomized to receive armodafinil 150 mg (n = 65), armodafinil 250 mg (n = 67), or placebo (n = 64) once daily for 12 weeks. MAIN OUTCOME MEASURES Efficacy was assessed using the Maintenance of… CONTINUE READING

Similar Papers

Loading similar papers…